Johnson & Johnson JNJ Stock Price, News & Info The Motley Fool

This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 . This is a lower news sentiment than the 0.77 average news sentiment score of Medical companies. Finder.com is an independent comparison platform and information service that aims to provide you with the tools https://dotbig.com/ you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site.

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Only 73 people have added Johnson & Johnson to their MarketBeat watchlist in the last 30 days. 173 people have searched for https://www.cmcmarkets.com/en/learn-forex/what-is-forex JNJ on MarketBeat in the last 30 days. MarketBeat has tracked 13 news articles for Johnson & Johnson this week, compared to 22 articles on an average week. MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

Motley Fool Returns

Provides a general description of the business conducted by this company. The pharmaceutical company’s golden goose is about to stop laying golden eggs, but that won’t be a permanent problem. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index Johnson & Johnson stock forecast quotes are real-time. Consumer stocks have provided some shelter from the storm, but Big Tech has resumed its decline. Former growth-stock darlings are now landing in the value stock bucket. All investments involve risks, including the loss of principal.

Access to Electronic Services may be limited or unavailable during periods of peak demand, market volatility, systems upgrade, maintenance, or for other reasons. In other news, the company is separating its consumer health division into a new company. This will allow J&J to JNJ focus on high-growth products, including its drugs and medical devices. In 2021, those units generated more than $79 billion in sales. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors.

During the second quarter, Johnson & Johnson earned $2.59 per share on $24.02 billion in dotbig sales. Johnson & Johnson announced a quarterly dividend on Wednesday, October 19th.

Key Earnings Data

Based on earnings estimates, Johnson & Johnson will have a dividend payout ratio of 44.01% next year. This indicates that Johnson & Johnson will be able to sustain or increase its dividend. This payout Forex ratio is at a healthy, sustainable level, below 75%. According to analysts’ consensus price target of $181.33, Johnson & Johnson has a forecasted upside of 2.3% from its current price of $177.24.

• The site you’re being redirected to is a branded pharmaceutical website.
• Intraday data delayed at least 15 minutes or per exchange requirements.
• Its banking subsidiary, Charles Schwab Bank, SSB , provides deposit and lending services and products.
• Last year, Johnson & Johnson brought in $93.78 billion in sales, popping nearly 14%.
• The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries.

Finder is not an advisor or brokerage service, and we don’t recommend investors to trade specific stocks or other investments. You can read more about the power of momentum in assessing share price movements on Stockopedia.

About Johnson & Johnson (NYSE:JNJ) Stock

The company’s average rating score is 2.36, and is based on 4 buy ratings, 7 hold ratings, and no sell ratings. Provide specific products and services to you, such as portfolio management or data aggregation. Shares https://dotbig.com/ Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report.

Social Links

These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.

Shares of J&J have an Investor’s Business Daily Composite Rating of 74 out of a best-possible 99. The CR scores a stock’s key growth metrics against all other stocks regardless of industry group. So in terms of key growth measures, outranks 74% of all stocks.

Best Roth IRA Stocks To Buy According To Hedge Funds

The company provided EPS guidance of $10.02-$10.07 for the period, compared to the consensus earnings per share estimate of $10.03. The company issued revenue guidance of $93.00 billion-$93.50 billion, compared to the consensus revenue estimate of $94.85 billion. Johnson & Johnson dotbig has a short interest ratio (“days to cover”) of 1.7, which is generally considered an acceptable ratio of short interest to trading volume. Johnson & Johnson has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.51% per year. These returns cover a period from https://dotbig.com/markets/stocks/JNJ/ January 1, 1988 through September 12, 2022. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month.